Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. Rev Diabet Stud [Internet]. 2026 Jun. 12 [cited 2026 Jun. 12];:62-76. Available from: https://diabeticstudies.org/index.php/RDS/article/view/2052